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Abstract
Background
In many infectious diseases, a core group of individuals plays a disproportionate role in
transmission. If these individuals were effectively prevented from transmitting infection, for
example with a perfect vaccine, then the disease would disappear in the remainder of the
community. No vaccine has yet proven effective against the ocular strains of chlamydia that
cause trachoma. However, repeated treatment with oral azithromycin may be able to pre-
vent individuals from effectively transmitting trachoma.
Methodology/Principal findings
Here we assess several methods for identifying a core group for trachoma, assuming vary-
ing degrees of knowledge about the transmission process. We determine the minimal core
group from a completely specified model, fitted to results from a large Ethiopian trial. We
compare this benchmark to a core group that could actually be identified from information
available to trachoma programs. For example, determined from the rate of return of infection
in a community after mass treatments, or from the equilibrium prevalence of infection.
Conclusions/Significance
Sufficient groups are relatively easy for programs to identify, but will likely be larger than the
theoretical minimum.
Author summary
Public health programs can in theory target treatment to a core group of individuals
responsible for a disproportionate amount of transmission. The smallest group of individ-
uals who need to be vaccinated to eventually eliminate an infectious disease is easy to find
in theory, but not in practice. While no vaccine has proven effective for trachoma,
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intensive periodic treatment may be able to effectively prevent individuals from transmit-
ting infection. Here we use a variety of methods to find a core group for trachoma trans-
mission, including methods that use information available to trachoma programs. We
show that the rate that infection returns into a community after mass treatment, or the
pre-treatment prevalence of an infectious disease should work, but will include more indi-
viduals than the theoretical minimum core group.
Introduction
Core groups can play a disproportionate role in transmission of an infectious disease [1–3]. If
transmission were terminated in this group, the disease would by definition eventually disap-
pear in the entire community [1]. Important key populations have been proposed for sexually
transmitted infections such as gonorrhea and HIV, as well as non-sexually transmitted diseases
such as trachoma [3–10]. For vaccine-preventable diseases, the group sufficient to vaccinate to
achieve herd immunity constitutes a core group. No vaccine has yet been proven effective for
trachoma. However, intensive drug administration could effectively remove a core group from
transmission, preventing infection from being sustainable in the remainder of the community
[5].
Young age and previous infection are by far the largest risk factors for transmission of ocu-
lar chlamydia, the causative organism of trachoma [11, 12]. Children have a longer duration of
infection and higher load than adults [13, 14]. In one study, repeated targeting of children
reduced infection in untreated adults, suggesting a form of herd protection [15]. In another,
essentially no infection could be found in adults after three years of repeated treatment of chil-
dren [16]. A modeling study suggested that treating children under 10 annually could eventu-
ally eliminate infection, limiting treatment to those under 5 years might require quarterly
treatments to achieve a similar result [5]. Another important risk factor is prior infection.
Those with clinical or laboratory findings of trachoma at one time point are at high risk at sub-
sequent time points, even if cleared from infection in the interim, presumably due to special
vulnerability or critical placement in the transmission network [11, 17].
If all heterogeneities were identified and a mathematical transmission were completely
specified, then a minimum core group could be determined analytically. However, this is
rarely, if ever, feasible in practice. In this report, we hypothesize that a sufficient core group
can be identified knowing very little detail about transmission. We use results from a large
community-randomized trachoma trial to estimate a minimal core group for transmission.
We compare several methods of estimating a sufficient core group, assuming various levels of
information ranging from complete specification of the transmission dynamics to knowledge
of the equilibrium prevalence alone.
Methods
Sufficient core group estimation methods
Method A, Complete specification of transmission. If we assume that the precise model
is known, we can find the minimal proportion of children and adults to remove from the pop-
ulation to prevent a newly introduced infection from spreading. One way to model two strata
would be to estimate the transmission between children and adults in a 2x2 reproduction
matrix. The minimal core group would be the smallest number of children and adults neces-
sary to remove from transmission (S1 File). We use two strata (children and adults) for
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demonstration. The method is applicable to any number of strata as long as the reproduction
matrix is specified. While complete specification of the transmission model may be impossible
in practice, here it serves as a benchmark for other methods.
Methods B and C, Linear Programming. If an infectious case in a homogeneous popula-
tion on average causes less than one new infectious case, then infection cannot be sustained (in
the absence of any positive feedback for infections). Here, we divide individuals into two
homogenous groups of children and adults, and we remove enough individuals from transmis-
sion that an infected child on average infects less than one other individual (child or adult),
and similarly for an adult. This would ensure that those removed form a sufficient core group,
and that the overall R for the community is less than one [1]. The goal is always feasible, as
long as enough individuals are removed from transmission. Knowledge of the reproduction
matrix allows this to be formulated as a linear programming problem, maximizing a linear
function given a set of linear inequality constraints. A linear program has a dual solution,
which is also core group (C) (see S1 File) [18]. If both the primal and the dual have solutions
that include both children and adults, they necessarily sum to the same total number of indi-
viduals (Duality Theorem) [18]. These methods require that we know that no individual is
expected to successfully transmit infection to more than one other person, which would be dif-
ficult to determine in practice. In general, neither of the solutions is optimal.
Method D. Rate of return of infection into a community following mass treatment. In
practice, we typically know little about the heterogeneities in transmission, and certainly not
enough to accurately estimate components of a next generation R matrix. However, studies
have estimated the rate that infection returns into a community after mass antibiotic distribu-
tion [5, 19]. If combined with knowledge of the average duration of infection, we can estimate
a growth rate per generation of infection, which is closely related to the maximum eigenvalue
(λ) of the R matrix, and suggests a method for ensuring a sufficient core group. If we remove
from transmission at least the proportion 1-1/λ of each stratum, then infection can no longer
be sustained in the community (see S1 File) [5, 13, 19, 20]. Note that for a given rate of return,
a longer duration of infection would increase the estimate of the size of the core group.
Method E. Equilibrium. In trachoma programs a pre-treatment survey is often per-
formed before programmatic activity. If conditions are relatively stable, then this prevalence
represents an estimate of the equilibrium. By definition, at equilibrium each infectious case
causes on average a single new infectious case. If we were to remove from transmission at least
the equilibrium proportion for each stratum of the population, then infection would no longer
be sustainable. Here we implement with two strata, although this approach applies in general
to any number of strata.
In some areas of Ethiopia, up to 10 years of annual mass drug administrations have failed to
completely eliminate infection [21]. The prevalence of clinical signs has been reduced but over
the past several years remained relatively stable, suggesting a new, reduced equilibrium. This
new restricted equilibrium could also represent a sufficient core group, although only if annual
mass distributions continued.
Three scenarios modeled
To explore the 5 different methods for determining a sufficient core group under different
conditions, we modeled 3 possible scenarios:
Scenario I. To mimic a region hyperendemic for trachoma before any programmatic
activity, we used a simple susceptible-infectious-susceptible (SIS) model that had previously
been fitted to results from a cluster-randomized trial in Amhara, Ethiopia (TANA, NEI U10
EY016214) [15, 16, 22]. Infection was monitored in 0–10 year olds (“children”) and in those
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older than 10 years (“adults”). Estimates of the transmission between children and adults had
previously been made, defining estimated reproduction matrix for children and adults. This
model can be used to compare 5 methods (A-E) of determining a sufficient core group (see S1
File) [15, 16, 22].
Scenario II. In some areas hyperendemic for trachoma, a decade of annual mass treat-
ment has failed to eliminate infection, resulting in a new reduced equilibrium [21]. We have
constructed a reproduction matrix which is reduced from Scenario I due to the continued
annual mass treatment, assuming annual antibiotic coverage for 5 years.
Scenario III. To demonstrate how the possible core groups would change if both children
and adults were substantial contributors to transmission, we constructed a hypothetical com-
munity in which members of both the children and adult segments of the population could
themselves sustain infection. Note that members from each stratum would need to be included
in any core group.
Results
The total proportion of children and adults that form a core group was determined using each
of the 5 methods, for each of the three scenarios (Table 1). For explanatory purposes, the total
proportion in the population was estimated assuming that children and adults were each one
half of the population, although it is not difficult to adjust this ratio. Note that approximately
half the population in these areas may be 18 years and under, one third 10 years and under,
and one-sixth under the age of 5 years.
Table 1. Results for 3 scenarios modeled.
Scenario R Matrix Total proportion of
population
I
Hyperendemic for trachoma, Pretreatment
1.39 0.67 A 0.32
B 0.47
1.48 0.28 C 0.64
D 0.49
E 0.48
II Hyperendemic for trachoma, Postreatment 0.95 0.38 A 0.15
B 0.19
0.83 0.33 C n/a
D 0.22
E 0.21
III
Children and Adults
1.45 0.25 A 0.45
B 0.46
0.48 1.52 C 0.46
D 0.45
E 0.45
For each of three scenarios I-III modeled, the R matrix is given in the center column. The 4 cells of each R matrix
reveal the average number of secondary infectious cases caused by a single infectious case in a totally susceptible
population. The upper left is the number of child cases caused by a single child case, the upper right child cases
caused by an adult case, lower left adult cases caused by a child case, and lower right adult cases caused by an adult
case. Within each scenario, the total proportion of the population for the 5 models A-E is also presented (A.
Complete specification of transmission, B. Primal Linear Programming, C. Dual Linear Programming, D. Largest
Perron eigenvalue, E. Equilibrium).
https://doi.org/10.1371/journal.pntd.0006478.t001
Identifying a sufficient core group for trachoma transmission
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006478 October 8, 2018 4 / 11
Scenario I
Given a transmission model estimated from the TANA study, the theoretical minimum core
group includes 64% of the children and none of the adults for a total of 32% of the total popula-
tion (Fig 1 and Table 1). Sufficient core groups using linear programming, the maximum
eigenvalue, or the equilibrium prevalence included more than twice the total number of
individuals.
Fig 1. An area hyperendemic for trachoma (Scenario I). The x-axis is the proportion of children that are in a potential core group, and the y-
axis is the proportion of adults. The black curve represents those proportions where the resulting reproduction number (R) of transmission in
the entire population equals unity. If the proportion of children and adults represented by any combination above and to the right of this
curve (the white, non-shaded area) were removed from transmission, infection could not be sustained in the rest of the population. Thus, all
combinations in the white area represent sufficient core groups. Point A represents the minimal core group whose removal would result in
eventual elimination of infection. Point B and C represent sufficient core groups determined by linear programming, point D from the
maximum eigenvalue of the transmission matrix (estimated directly from the return of infection into a community and the average duration
of infection), and point E from the equilibrium, pre-treatment prevalence of infection.
https://doi.org/10.1371/journal.pntd.0006478.g001
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Scenario II
In the presence of years of mass annual treatment, a new equilibrium may be reached. Here,
21% of children and adults remain affected. A residual core group remains, in the presence of
the annual treatments (Fig 2, Table 1). The sufficient core groups obtained from the rate of
return of infection and from the residual equilibrium are still larger as the theoretical mini-
mum of 15%, including 21–22% of the population.
Fig 2. After a decade of annual mass antibiotic distributions (Scenario II). Infection has still not been eliminated in some areas of Ethiopia.
The prevalence of infection has reached a new, residual equilibrium in the presence of the continued treatments. The residual core group is
smaller than the core group in Scenario I. If this group were targeted and mass treatments were continued, we would expect infection to
eventually disappear. The minimal core group (A) includes only children, but the strategies based on the rate of return of infection (D) and the
residual equilibrium (E) may offer practical, reasonably efficient strategies. The dual linear programming solution is not feasible here, and is
not represented.
https://doi.org/10.1371/journal.pntd.0006478.g002
Identifying a sufficient core group for trachoma transmission
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Scenario III
In the most severely affected areas, transmission can be sustained in either the children alone
or the adults alone. Therefore, all sufficient core groups would necessarily include both chil-
dren and adults. Here, the more practical methods approach the theoretical minimum (Fig 3,
Table 1). In this scenario, both the primal (B) and dual (C) linear programs have identified
core groups that contain both children and adults. Although the combinations are different,
they contain the same number of individuals as demonstrated by the second (higher) grey iso-
population line, as guaranteed by the Duality Theorem [18]. Note that transmission in adults
in this scenario is likely unrealistically high, although we have included it as an illustrative
example.
Fig 3. A hyper-endemic community where transmission can be sustained in either the children alone or the adults alone (Scenario III).
Here, all solutions are similar to the theoretical minimum core group (A). The primal and dual linear programming solutions contain
different combinations of children and adults, but contain the same overall total [18].
https://doi.org/10.1371/journal.pntd.0006478.g003
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Discussion
A group of individuals who play a disproportionate role in the transmission of an infectious
disease has been described by a number of terms, including key population, hyper-spreaders,
and core group [10, 23]. A stricter definition of a core group would be those individuals whose
removal from transmission would be sufficient to prevent infectious trachoma from sustaining
itself in the entire community [1, 24]. Here, we have assumed that the process can be described
by a mathematical transmission model in which individuals can be divided into a number of
compartments, each one of which is homogeneous. From such a model, a sufficient core
group can be estimated in a number of ways. As a relatively simple case, we divide a trachoma-
endemic population into children and adults, and fit a simple model to data from a commu-
nity-randomized trial in Ethiopia [15]. The fitted model allows a sufficient core group to be
estimated using a number of methods. The smallest group whose removal from transmission
results in the remainder of the population producing on average less than one case per infec-
tious case. Under certain circumstances, the dual of this linear programming problem also
may be a sufficient core group. If the dominant eigenvalue of a next generation matrix of the
transmission model and the average duration of infectious cases in each of the groups are
defined, then a sufficient core group can easily be determined. If the entire model is specified,
then the absolute minimum sized core group can be found.
Even when the precise details of the transmission model are not understood, a sufficient
core group can still be estimated from epidemiological data. If we limit analysis to diseases that
do not confer lifelong immunity and where current infection is a risk factor for future reinfec-
tion, then removal of those currently infected from future transmission would control the dis-
ease, leading to eventual elimination. For example, if infection is reduced by repeated mass
antibiotic distributions given to the entire community, then it should return at a rate depen-
dent on the maximum eigenvalue of the next generation matrix. If the average duration of
infection is known, then the dominant eigenvalue of this matrix can be estimated. If all but the
proportion equal to the reciprical of this eigenvalue were removed from each compartment,
then infection would eventually disappear.
A more practical method for determining a sufficient core group requires knowledge of
who was infected prior to treatment. If we assume that current infection is a risk factor for
future reinfection. This allows determination of a core group in two settings: at the beginning
of a program when transmission may have reached an equilibrium, and after years of annual
MDA with a new equilibrium. In the former, the goal would be to find the group of people
whose effective removal from transmission would lead to eventual elimination in everyone.
Community-randomized trials have found that if a core group of children are effectively
removed from transmission by quarterly antibiotic treatments, infection decreases in the
remainder of the community [15]. If mass antibiotics are repeated, elimination can be achieved
even though not everyone was actually treated. In the setting where years of annual mass treat-
ment have not eliminated infection, then the goal might be to find a residual core group whose
removal from transmission would result in elimination if future annual mass treatment were
also continued. In several areas, more than 5 years of mass azithromycin distributions have left
a small amount of persistent infection [25, 26]. This group could represent a residual core
group.
The equilibrium approach to finding a sufficient core group is dependent on a number of
assumptions. For the equilibrium to form a core group, currently infected cases must be at
least as likely to participate in future transmission as uninfected cases. This would not be true
for an infection where acquired immunity outweighs other risk factors. Note that removing
those infected at equilibrium from transmission would be expected to work regardless of
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whether we understand the heterogeneity in the community. Underestimates of prevalence
would lead to models underestimating the size of the core group. We modeled 3 scenarios of
different endemicity, reflecting different transmission. Future study could explore scenarios
with an even broader spectrum of heterogeneity. While method 1 assumed an SIS model struc-
ture, that is not necessary for the other methods. However, we have assumed that current
infection is a risk factor for future infection, or at least does not offer protection. If this
assumption were violated, more analysis would be necessary.
Sufficient core groups can be estimated from information available to trachoma control
programs. The use of WHO simplified grades rather than infection data would result in a
larger, more conservative estimate of the core group. In moderately affected areas, information
taken from baseline surveys could be used to reduce the proportion of the population treated.
In the few severely affected areas where residual core group indicates that annual MDA is inad-
equate, enhanced targeting of a core group might be necessary for elimination. Enhanced
intervention targeted to core groups would require additional resources, but may be the final
key for successful trachoma control. Resources can be directed towards core groups at the
beginning of a program, or towards a residual core groups resistant to elimination in the pres-
ence of standard annual mass azithromycin distribution [21]. Precise transmission models are
not absolutely necessary to estimate sufficient core groups. These models are hypothesis gener-
ating. While strategies based on core groups have been tested in community-randomized tri-
als, the efficacy of a strategy based on residual core groups will need to be tested in current and
future trials (U10 EY023939 and UG1 EY028088) [15, 16, 27].
Supporting information
S1 File. Methods A-E. Additional details are provided for Methods A-E.
(PDF)
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